List of works - Arthur Machlenkin

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

scientific article published on 8 December 2016

A high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes

scientific article

Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cells

scientific article

Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs

scientific article

Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.

scientific article published in July 2005

Exuberated numbers of tumor-specific T cells result in tumor escape.

scientific article

Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy

scientific article published on July 2005

Human T cell crosstalk is induced by tumor membrane transfer

scientific article (publication date: 2015)

Identification of novel immune checkpoints as targets for cancer immunotherapy.

scientific article published on 6 November 2014

Imprinting of Lymphocytes with Melanoma Antigens Acquired by Trogocytosis Facilitates Identification of Tumor-Reactive T Cells ⬇️

scientific article published on April 26, 2013

In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.

scientific article published on March 2004

Mouse PVRIG Has CD8+ T Cell-Specific Coinhibitory Functions and Dampens Antitumor Immunity

scientific article published on 18 January 2019

Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice.

scientific article

Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-melanoma Activity In Vivo

scientific article published on 5 January 2018

Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells.

scientific article published on 12 October 2011

T-cell seeding: neonatal transfer of anti-myelin basic protein T-cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis

scientific article

Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune response ⬇️

scientific article published on September 18, 2010

Trogocytosis Is a Gateway to Characterize Functional Diversity in Melanoma-Specific CD8+ T Cell Clones ⬇️

scientific article published on December 7, 2011

List of works by Arthur Machlenkin

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

A high-throughput RNAi screen for detection of immune-checkpoint molecules that mediate tumor resistance to cytotoxic T lymphocytes

Autologous melanoma vaccine induces antitumor and self-reactive immune responses that affect patient survival and depend on MHC class II expression on vaccine cells

Capture of tumor cell membranes by trogocytosis facilitates detection and isolation of tumor-specific functional CTLs

Combined dendritic cell cryotherapy of tumor induces systemic antimetastatic immunity.

Exuberated numbers of tumor-specific T cells result in tumor escape.

Human CTL epitopes prostatic acid phosphatase-3 and six-transmembrane epithelial antigen of prostate-3 as candidates for prostate cancer immunotherapy

Human T cell crosstalk is induced by tumor membrane transfer

Identification of novel immune checkpoints as targets for cancer immunotherapy.

Imprinting of Lymphocytes with Melanoma Antigens Acquired by Trogocytosis Facilitates Identification of Tumor-Reactive T Cells ⬇️

In vivo rejection of tumor cells dependent on CD8 cells that kill independently of perforin and FasL.

Mouse PVRIG Has CD8+ T Cell-Specific Coinhibitory Functions and Dampens Antitumor Immunity

Preventive and therapeutic vaccination with PAP-3, a novel human prostate cancer peptide, inhibits carcinoma development in HLA transgenic mice.

Soluble SLAMF6 Receptor Induces Strong CD8+ T-cell Effector Function and Improves Anti-melanoma Activity In Vivo

Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells.

T-cell seeding: neonatal transfer of anti-myelin basic protein T-cell lines renders Fischer rats susceptible later in life to the active induction of experimental autoimmune encephalitis

Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune response ⬇️

Trogocytosis Is a Gateway to Characterize Functional Diversity in Melanoma-Specific CD8+ T Cell Clones ⬇️